Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Ex Ante Announcement - Rsv Immunoglobulin

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) Netherlands has Released a tender for Ex Ante Announcement - Rsv Immunoglobulin in Pharmaceuticals. The tender was released on Jan 30, 2025.

Country - Netherlands

Summary - Ex Ante Announcement - Rsv Immunoglobulin

Deadline - login to view

GT reference number - 102488556

Product classification - Immunoglobulins

Organization Details:

  Address - Netherlands

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102488556

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: On 14 February 2024, the Health Council (GR) submitted an advice to the State Secretary of Health, Welfare and Sport on immunising children against respiratory syncytial virus (RSV) in their first year of life. The council advises that a ll children in their first year of life should be offered protection against RSV in the short term through the National Vaccination Programme (RVP) by administering antibodies (immunisation with the antibody nirsevimab). Based on the GR advice and the results of the RIVM exploration, the State Secretary of Health, Welfare and Sport has decided to add RSV immunisation to the RVP in 2025.local title:: Ex Ante aankondiging - RSV immunoglobulinContra

Gt Ref Id - 102488556

Deadline - Nov 30, -0001

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database